Wealthfront Advisers LLC

SEC CIK: 0001763921
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by Wealthfront Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overview All 13F holders of NTLA Full Q2 2026 holdings

Shares (Q2 2026): 18,196
Value: $307.9K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of NTLA by Wealthfront Advisers LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	18,196	$307.9K	<0.1%	+3,746+25.9%	Added	Holders
Q1 2026	14,450	$185.2K	<0.1%	+1,018+7.6%	Added	Holders
Q4 2025	13,432	$120.8K	<0.1%	+13,432	New	Holders